Koers Callitas Health Inc. Canadian Securities Exchange
Aandelen
LILY
CA13125C1068
Biotechnologie & Medisch Onderzoek
Omzet 2018 | 0,75 1,03 0,7 | Omzet 2019 | 0,71 0,97 0,66 | Marktkapitalisatie | 3,53 mln. 4,82 mln. 3,27 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -5 mln. -6,84 mln. -4,64 mln. | Nettowinst (verlies) 2019 | -1 mln. -1,37 mln. -927K | EV/omzet 2018 | 4.852.616 x |
Nettoschuld 2018 | 319K 436K 296K | Nettoschuld 2019 | 848K 1,16 mln. 786K | EV/omzet 2019 | 6.168.166 x |
K/w-verhouding 2018 |
-0,6
x | K/w-verhouding 2019 |
-1,97
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 72,04% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 03-01-18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01-12-14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+24,31% | 46,71 mld. | |
+48,83% | 41,8 mld. | |
-0,94% | 41,52 mld. | |
-5,86% | 29,55 mld. | |
+11,21% | 25,78 mld. | |
-20,90% | 19,26 mld. | |
+2,95% | 12,14 mld. | |
-2,20% | 12,08 mld. | |
+30,60% | 11,98 mld. |